Epidemiology of Herpes Zoster in the pre-vaccination era: establishing the baseline for vaccination programme’s impact in Spain

BACKGROUND: Herpes zoster (HZ) affects 1 in 3 persons in their lifetime, and the risk of HZ increases with increasing age and the presence of immunocompromising conditions. In Spain, vaccination guidelines were recently updated to include the recommendation of the new recombinant zoster vaccine (RZV...

Descripción completa

Detalles Bibliográficos
Autores principales: Risco Risco, Carlos, Herrador, Zaida, Lopez-Parea, Noemí, Martínez-Urbistondo, Diego, del Villar Carrero, Rafael Suárez, Masa-Calles, Josefa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951257/
https://www.ncbi.nlm.nih.gov/pubmed/36820639
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.8.2200390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951257/
https://www.ncbi.nlm.nih.gov/pubmed/36820639
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.8.2200390

Ejemplares similares